Dyslipidemia and Thyroid Dysfunction Associated with Psoriasis

Area of Science:

• Endocrinology
• Dermatology
• Cardiovascular Medicine

Background:

• Psoriasis is a T-cell mediated inflammatory skin disease impacting quality of life.
• Shared inflammatory pathways link psoriasis with thyroid dysfunction.
• Psoriasis increases cardiovascular event risk, with dyslipidemia as a key factor.

Purpose of the Study:

• To evaluate thyroid function and lipid profiles in psoriasis patients.
• To investigate the association between psoriasis, thyroid dysfunction, and dyslipidemia.

Main Methods:

• Prospective case-control study with 76 psoriasis patients and 80 controls.
• Assessed thyroid function tests (free T3, T4, TSH).
• Analyzed lipid profiles (total cholesterol, LDL, HDL, triglycerides).

Main Results:

• Hypothyroidism was observed in 13.15% of psoriasis patients.
• Psoriasis patients exhibited significantly higher lipid profile parameters (p<0.001).
• Psoriasis patients were 2.8 times more likely to have thyroid dysfunction and 8.7 times more likely to have dyslipidemia.

Conclusions:

• Thyroid dysfunction and dyslipidemia are common comorbidities in psoriasis.
• Assessing thyroid function and lipid profiles is recommended for psoriasis patients.
• These assessments aid in understanding psoriasis pathogenesis and managing comorbidities.